Hong Kong · Delayed Price · Currency is HKD Duality Biotherapeutics Statistics
Total Valuation
HKG:9606 has a market cap or net worth of HKD 20.17 billion. The enterprise value is 16.57 billion.
| Market Cap | 20.17B |
| Enterprise Value | 16.57B |
Important Dates
The last earnings date was Monday, March 23, 2026.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9606 has 90.43 million shares outstanding. The number of shares has increased by 714.45% in one year.
| Current Share Class | 90.43M |
| Shares Outstanding | 90.43M |
| Shares Change (YoY) | +714.45% |
| Shares Change (QoQ) | +112.47% |
| Owned by Insiders (%) | 12.72% |
| Owned by Institutions (%) | 36.33% |
| Float | 50.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.79 |
| PB Ratio | 7.47 |
| P/TBV Ratio | 7.48 |
| P/FCF Ratio | 98.98 |
| P/OCF Ratio | 93.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.74 |
| EV / Sales | 8.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 81.33 |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.65 |
| Quick Ratio | 3.52 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.82 |
| Interest Coverage | -380.27 |
Financial Efficiency
Return on equity (ROE) is -1,282.14% and return on invested capital (ROIC) is -102.74%.
| Return on Equity (ROE) | -1,282.14% |
| Return on Assets (ROA) | -9.61% |
| Return on Invested Capital (ROIC) | -102.74% |
| Return on Capital Employed (ROCE) | -16.20% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 8.92M |
| Profits Per Employee | -12.50M |
| Employee Count | 231 |
| Asset Turnover | 0.62 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.23% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.23% |
| 50-Day Moving Average | 274.87 |
| 200-Day Moving Average | 321.87 |
| Relative Strength Index (RSI) | 32.84 |
| Average Volume (20 Days) | 890,699 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9606 had revenue of HKD 2.06 billion and -2.89 billion in losses. Loss per share was -44.32.
| Revenue | 2.06B |
| Gross Profit | 655.55M |
| Operating Income | -512.03M |
| Pretax Income | -2.89B |
| Net Income | -2.89B |
| EBITDA | -503.77M |
| EBIT | -512.03M |
| Loss Per Share | -44.32 |
Balance Sheet
The company has 3.76 billion in cash and 166.67 million in debt, with a net cash position of 3.59 billion or 39.75 per share.
| Cash & Cash Equivalents | 3.76B |
| Total Debt | 166.67M |
| Net Cash | 3.59B |
| Net Cash Per Share | 39.75 |
| Equity (Book Value) | 2.70B |
| Book Value Per Share | 30.20 |
| Working Capital | 3.10B |
Cash Flow
In the last 12 months, operating cash flow was 216.53 million and capital expenditures -12.80 million, giving a free cash flow of 203.73 million.
| Operating Cash Flow | 216.53M |
| Capital Expenditures | -12.80M |
| Depreciation & Amortization | 8.58M |
| Net Borrowing | 157.80M |
| Free Cash Flow | 203.73M |
| FCF Per Share | 2.25 |
Margins
Gross margin is 31.81%, with operating and profit margins of -24.85% and -140.13%.
| Gross Margin | 31.81% |
| Operating Margin | -24.85% |
| Pretax Margin | -140.13% |
| Profit Margin | -140.13% |
| EBITDA Margin | -24.45% |
| EBIT Margin | -24.85% |
| FCF Margin | 9.89% |
Dividends & Yields
HKG:9606 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -714.45% |
| Shareholder Yield | -714.45% |
| Earnings Yield | -14.32% |
| FCF Yield | 1.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:9606 is 433.97, which is 94.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 433.97 |
| Price Target Difference | 94.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:9606 has an Altman Z-Score of 9.2 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.2 |
| Piotroski F-Score | 2 |